Your browser doesn't support javascript.
loading
Declining mortality in older people with type 2 diabetes masks rising excess risks at younger ages: a population-based study of all-cause and cause-specific mortality over 13 years.
Sacre, Julian W; Harding, Jessica L; Shaw, Jonathan E; Magliano, Dianna J.
Afiliación
  • Sacre JW; Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Australia.
  • Harding JL; Department of Surgery, Division of Transplantation, Emory University School of Medicine, Atlanta, GA, USA.
  • Shaw JE; Clinical Diabetes and Epidemiology, Baker Heart and Diabetes Institute, Melbourne, Australia.
  • Magliano DJ; Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, Australia.
Int J Epidemiol ; 50(4): 1362-1372, 2021 08 30.
Article en En | MEDLINE | ID: mdl-33462587
BACKGROUND: Excess mortality in people with vs without type 2 diabetes (T2DM) has fallen, but it is unclear whether men/women at all ages have benefited and which causes of death have driven these trends. METHODS: All-cause and cause-specific mortality rates and excess mortality [by mortality rate ratios (MRRs) relative to the non-diabetic general population] were examined in 1 268 018 Australians with T2DM registered on the National Diabetes Services Scheme (2002-2014). RESULTS: Age-standardized mortality decreased in men (-2.2%/year; Ptrend < 0.001) and women with T2DM (-1.3%/year; Ptrend < 0.001) throughout 2002-14, which translated to declines in the MRRs (from 1.51 to 1.45 in men; 1.59 to 1.46 in women; Ptrend < 0.05 for both). Declining mortality rates in T2DM were observed in men aged 40+ years and women aged 60+ years (Ptrends <0.001), but not at younger ages. However, the only age group in which excess mortality declined relative to those without diabetes was 80+ years (Ptrends < 0.05); driven by reductions in excess cancer-related deaths in men and cardiovascular disease (CVD) in women. Among age groups <80 years, CVD and cancer MRRs remained similar or increased over time, despite falls in both CVD and cancer mortality rates. MRRs for non-CVD/non-cancer-related deaths increased in 60-79 year-olds, but were otherwise unchanged. CONCLUSIONS: Declining excess mortality attributable to T2DM from 2002-14 was driven entirely by reductions in those aged 80+ years. Declines in total mortality among those with T2DM were apparent in more age groups, but often to a lesser extent than in the general population, thereby serving to increase the excess risk associated with T2DM.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Aged / Aged80 / Female / Humans / Male País/Región como asunto: Oceania Idioma: En Revista: Int J Epidemiol Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Aged / Aged80 / Female / Humans / Male País/Región como asunto: Oceania Idioma: En Revista: Int J Epidemiol Año: 2021 Tipo del documento: Article País de afiliación: Australia